Cargando…
Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China
Background: Danhong injection (DHI) accounts for the highest proportion of drug costs for inpatients with coronary heart disease (CHD). However, if DHI price influences utilization remains unclear. Objective: The objective was to compare changes in the use of DHI for CHD patients during three stages...
Autores principales: | Liu, Liming, Xu, Yue, Su, Zihan, Man, Xiaowei, Jiang, Yan, Zhao, Liying, Cheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114504/ https://www.ncbi.nlm.nih.gov/pubmed/35600876 http://dx.doi.org/10.3389/fphar.2022.857167 |
Ejemplares similares
-
The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Zou, Jun-Bo, et al.
Publicado: (2018) -
Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke
por: Li, Min, et al.
Publicado: (2018) -
Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Li, YiZhuo, et al.
Publicado: (2020) -
Danhong Injection Protects Hemorrhagic Brain by Increasing Peroxiredoxin 1 in Aged Rats
por: Wang, Shang, et al.
Publicado: (2020) -
Danhong Injection Reversed Cardiac Abnormality in Brain–Heart Syndrome via Local and Remote β-Adrenergic Receptor Signaling
por: Orgah, John O., et al.
Publicado: (2018)